Clinical Trial Update: BIG Molecular Screening Feasibility Study [NA]

View source ↗

Summary

The BIG Molecular Screening Feasibility Study, sponsored by Jules Bordet Institute, for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Jules Bordet Institute | Conditions: Metastatic Breast Cancer | NA | Status: COMPLETED